{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:45:19Z","timestamp":1792233919105,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation of Hunan Province of China","award":["2024JJ4084"],"award-info":[{"award-number":["2024JJ4084"]}]},{"name":"Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University","award":["YX202207"],"award-info":[{"award-number":["YX202207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"DOI":"10.1007\/s11845-026-04664-w","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:08:20Z","timestamp":1792231700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between the estimated small dense low-density lipoprotein cholesterol and multimorbidity: a national longitudinal study"],"prefix":"10.1007","author":[{"given":"Juan","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishun","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"issue":"19","key":"4664_CR1","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jacc.2018.03.022","volume":"71","author":"DE Forman","year":"2018","unstructured":"Forman DE, Maurer MS, Boyd C and others (2018) Multimorbidity in older adults with cardiovascular disease. J Am Coll Cardiol 71(19):2149\u20132161","journal-title":"J Am Coll Cardiol"},{"key":"4664_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101860","volume":"57","author":"SR Chowdhury","year":"2023","unstructured":"Chowdhury SR, Chandra Das D, Sunna TC and others (2023) Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine 57:101860","journal-title":"EClinicalMedicine"},{"issue":"10","key":"4664_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004109","volume":"19","author":"S Sabia","year":"2022","unstructured":"Sabia S, Dugravot A, L\u00e9ger D and others (2022) Association of sleep duration at age 50, 60, and 70 years with risk of multimorbidity in the UK: 25-year follow-up of the Whitehall II cohort study. PLoS Med 19(10):e1004109","journal-title":"PLoS Med"},{"key":"4664_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101901","volume":"87","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Dai X, Ni Y and others (2023) Interventions and management on multimorbidity: an overview of systematic reviews. Ageing Res Rev 87:101901","journal-title":"Ageing Res Rev"},{"issue":"4","key":"4664_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","volume":"10","author":"A Marengoni","year":"2011","unstructured":"Marengoni A, Angleman S, Melis R and others (2011) Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 10(4):430\u2013439","journal-title":"Ageing Res Rev"},{"key":"4664_CR6","unstructured":"Ryd\u00e9n L, Standl E, Bartnik M et al (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28(1):88\u2013136"},{"issue":"1","key":"4664_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL and others (2019) 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111\u2013188","journal-title":"Eur Heart J"},{"issue":"21","key":"4664_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113499","volume":"23","author":"H Yanai","year":"2022","unstructured":"Yanai H, Adachi H, Hakoshima M and others (2022) Atherogenic lipoproteins for the statin residual cardiovascular disease risk. Int J Mol Sci 23(21):13499","journal-title":"Int J Mol Sci"},{"issue":"16","key":"4664_CR9","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.111.088591","volume":"125","author":"S Mora","year":"2012","unstructured":"Mora S, Wenger NK, Demicco DA and others (2012) Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation 125(16):1979\u20131987","journal-title":"Circulation"},{"issue":"10","key":"4664_CR10","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.5551\/jat.63229","volume":"29","author":"J Ishii","year":"2022","unstructured":"Ishii J, Kashiwabara K, Ozaki Y and others (2022) Small dense low-density lipoprotein cholesterol and cardiovascular risk in statin-treated patients with coronary artery disease. J Atheroscler Thromb 29(10):1458\u20131474","journal-title":"J Atheroscler Thromb"},{"key":"4664_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cca.2021.06.012","volume":"520","author":"C Kanonidou","year":"2021","unstructured":"Kanonidou C (2021) Small dense low-density lipoprotein: analytical review. Clin Chim Acta 520:172\u2013178","journal-title":"Clin Chim Acta"},{"issue":"27","key":"4664_CR12","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1093\/eurheartj\/ehy387","volume":"39","author":"U Laufs","year":"2018","unstructured":"Laufs U, Weing\u00e4rtner O (2018) Pathological phenotypes of LDL particles. Eur Heart J 39(27):2574\u20132576","journal-title":"Eur Heart J"},{"issue":"3","key":"4664_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MOL.0000000000000067","volume":"25","author":"MR Diffenderfer","year":"2014","unstructured":"Diffenderfer MR, Schaefer EJ (2014) The composition and metabolism of large and small LDL. Curr Opin Lipidol 25(3):221\u2013226","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"4664_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.26598","volume":"93","author":"M Balling","year":"2023","unstructured":"Balling M, Nordestgaard BG, Varbo A and others (2023) Small dense low-density lipoprotein cholesterol and ischemic stroke. Ann Neurol 93(5):952\u2013964","journal-title":"Ann Neurol"},{"issue":"5","key":"4664_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","volume":"34","author":"RC Hoogeveen","year":"2014","unstructured":"Hoogeveen RC, Gaubatz JW, Sun W and others (2014) Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol 34(5):1069\u20131077","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"4664_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5664\/jcsm.1768","volume":"8","author":"FS Luyster","year":"2012","unstructured":"Luyster FS, Kip KE, Drumheller OJ and others (2012) Sleep apnea is related to the atherogenic phenotype, lipoprotein subclass B. J Clin Sleep Med 8(2):155\u2013161","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"4664_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01668-5","volume":"21","author":"Y Chen","year":"2022","unstructured":"Chen Y, Fu Y, Wang S, Chen P, Pei Y, Zhang J, Zhang R, Niu G, Gu F, Li X (2022) Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged\u2009\u2265\u200965 years. Cardiovasc Diabetol 21(1):252","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4664_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP and others (2014) Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol 43(1):61\u201368","journal-title":"Int J Epidemiol"},{"issue":"1","key":"4664_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24807","volume":"37","author":"HK Kim","year":"2023","unstructured":"Kim HK, Hong J, Ahn S and others (2023) Association between measured or calculated small dense low-density lipoprotein cholesterol and oxidized low-density lipoprotein in subjects with or without type 2 diabetes mellitus. J Clin Lab Anal 37(1):e24807","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"4664_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","volume":"5","author":"M Sampson","year":"2020","unstructured":"Sampson M, Ling C, Sun Q and others (2020) A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia. JAMA Cardiol 5(5):540\u2013548","journal-title":"JAMA Cardiol"},{"key":"4664_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jare.2024.12.015","volume":"76","author":"J Chen","year":"2025","unstructured":"Chen J, Wu Q, Liu H and others (2025) Predictive value of remnant cholesterol inflammatory index for stroke risk: evidence from the China health and retirement longitudinal study. J Adv Res 76:543\u2013552","journal-title":"J Adv Res"},{"key":"4664_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2020.128021","volume":"263","author":"Y Lv","year":"2021","unstructured":"Lv Y, Xie L, Dong C and others (2021) Co-exposure of serum calcium, selenium and vanadium is nonlinearly associated with increased risk of type 2 diabetes mellitus in a Chinese population. Chemosphere 263:128021","journal-title":"Chemosphere"},{"key":"4664_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110665","volume":"199","author":"T Ichikawa","year":"2023","unstructured":"Ichikawa T, Okada H, Hamaguchi M, Kurogi K, Murata H, Ito M, Fukui M (2023) Estimated small dense low-density lipoprotein-cholesterol and incident type 2 diabetes in Japanese people: population-based panasonic cohort study 13. Diabetes Res Clin Pract 199:110665","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"4664_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.5551\/jat.51961","volume":"27","author":"M Higashioka","year":"2020","unstructured":"Higashioka M, Sakata S, Honda T and others (2020) Small dense low-density lipoprotein cholesterol and the risk of coronary heart disease in a Japanese community. J Atheroscler Thromb 27(7):669\u2013682","journal-title":"J Atheroscler Thromb"},{"key":"4664_CR25","doi-asserted-by":"crossref","unstructured":"Balling M, Nordestgaard BG, Langsted A, Varbo A, Kamstrup PR, Afzal S (2025) The association between small dense low-density lipoprotein cholesterol and peripheral artery disease: a large-scale cohort study and meta-analysis. Eur J Prev Cardiol 14:zwaf305","DOI":"10.1093\/eurjpc\/zwaf305"},{"issue":"4","key":"4664_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/jdi.14133","volume":"15","author":"H Huang","year":"2024","unstructured":"Huang H, Xie J, Hou L and others (2024) Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations. J Diabetes Investig 15(4):491\u2013499","journal-title":"J Diabetes Investig"},{"issue":"2","key":"4664_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5551\/jat.12.67","volume":"12","author":"T Hirano","year":"2005","unstructured":"Hirano T, Ito Y, Yoshino G (2005) Measurement of small dense low-density lipoprotein particles. J Atheroscler Thromb 12(2):67\u201372","journal-title":"J Atheroscler Thromb"},{"issue":"10","key":"4664_CR28","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1161\/ATVBAHA.125.323157","volume":"45","author":"R Zubiran","year":"2025","unstructured":"Zubiran R, Sampson M, Wolska A and others (2025) Estimated small, dense LDL cholesterol and atherosclerotic cardiovascular risk in the UK Biobank. Arterioscler Thromb Vasc Biol 45(10):e512\u2013e522","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"4664_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02593-z","volume":"24","author":"Y Hu","year":"2025","unstructured":"Hu Y, Liang Y, Li J and others (2025) Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol 24(1):40","journal-title":"Cardiovasc Diabetol"},{"issue":"7709","key":"4664_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","volume":"558","author":"X Que","year":"2018","unstructured":"Que X, Hung MY, Yeang C and others (2018) Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558(7709):301\u2013306","journal-title":"Nature"},{"issue":"9","key":"4664_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1365-2362.2007.01849.x","volume":"37","author":"J Vekic","year":"2007","unstructured":"Vekic J, Kotur-Stevuljevic J, Jelic-Ivanovic Z and others (2007) Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. Eur J Clin Invest 37(9):715\u2013723","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"4664_CR32","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","volume":"95","author":"DA Chistiakov","year":"2017","unstructured":"Chistiakov DA, Melnichenko AA, Myasoedova VA and others (2017) Mechanisms of foam cell formation in atherosclerosis. J Mol Med (Berl) 95(11):1153\u20131165","journal-title":"J Mol Med (Berl)"},{"key":"4664_CR33","doi-asserted-by":"crossref","unstructured":"Goff DC Jr., D\u2019Agostino RB Jr., Haffner SM et al (2005) Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the insulin resistance atherosclerosis study. Metabolism 54(2):264\u2013270","DOI":"10.1016\/j.metabol.2004.09.002"},{"issue":"4","key":"4664_CR34","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/15701611113119990125","volume":"12","author":"PP Toth","year":"2014","unstructured":"Toth PP (2014) Insulin resistance, small LDL particles, and risk for atherosclerotic disease. Curr Vasc Pharmacol 12(4):653\u2013657","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"4664_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1309\/AJCPLHJBGG9L3ILS","volume":"136","author":"P Srisawasdi","year":"2011","unstructured":"Srisawasdi P, Chaloeysup S, Teerajetgul Y and others (2011) Estimation of plasma small dense LDL cholesterol from classic lipid measures. Am J Clin Pathol 136(1):20\u201329","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"4664_CR36","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12944-024-02345-0","volume":"23","author":"T Han","year":"2024","unstructured":"Han T, Piao Z, Yu Z and others (2024) An equation for calculating small dense low-density lipoprotein cholesterol. Lipids Health Dis 23(1):366","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4664_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12944-025-02717-0","volume":"24","author":"Y Ma","year":"2025","unstructured":"Ma Y, Zhai X, Mu D and others (2025) Superior prognostic value of estimated small dense LDL cholesterol for cardiovascular risk assessment: evidence from international cohort studies. Lipids Health Dis 24(1):321","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4664_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12902-025-01880-w","volume":"25","author":"Y Gao","year":"2025","unstructured":"Gao Y (2025) Association of estimated small dense low-density lipoprotein cholesterol with diabetes mellitus: a large-scale multicenter retrospective cohort study. BMC Endocr Disord 25(1):66","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"4664_CR39","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1038\/s41440-025-02374-x","volume":"48","author":"H Aida","year":"2025","unstructured":"Aida H, Tanaka M, Sato T and others (2025) Elevated level of estimated small dense LDL cholesterol is independently associated with the development of hypertension, regardless of LDL cholesterol level. Hypertens Res 48(12):3091\u20133100","journal-title":"Hypertens Res"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04664-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04664-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04664-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:08:22Z","timestamp":1792231702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04664-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":39,"alternative-id":["4664"],"URL":"https:\/\/doi.org\/10.1007\/s11845-026-04664-w","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"9 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CHARLS survey received ethical approval from the Institutional Review Board of Peking University (Approval No. IRB00001052-11015), and all participants provided written informed consent. This secondary analysis was approved by the Institutional Review Board of the Third Xiangya Hospital of Central South University (Approval No.: E 26600).","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}